Skip to content
Article Rich – Lifestyle
Author:
Immunic, Inc.
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 1, 2026
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
March 31, 2026
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
March 10, 2026
Immunic to Participate in Investor Conferences in March
March 5, 2026
←
Previous Page
1
2